1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Healthcare Shares

    Why is everyone talking about CSL shares?

    | Samantha Menzies

    CSL suffered a ‘brutal selloff’ this week.

    Read more »

    A man raises his reading glasses in a look of surprise.
    Cheap Shares

    These cheap ASX 200 shares could rise 25% to 30%

    | James Mickleboro

    These shares could be destined to deliver big returns for investors.

    Read more »

    Business people discussing project on digital tablet.
    Broker Notes

    Buy, hold, sell: BHP, CSL, and NAB shares

    | James Mickleboro

    Let's see what analysts at Morgans are saying about these popular stocks.

    Read more »

    A financial expert or broker looks worried as he checks out a graph showing market volatility.
    Healthcare Shares

    Is the CSL share price dirt cheap after crashing this week?

    | James Mickleboro

    Is this beaten down biotech cheap? Let's find out.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face.
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Here's what brokers are recommending as buys this week.

    Read more »

    woman crying while eating ice cream
    Share Fallers

    3 ASX heavyweights stumble on earnings results

    | Leigh Gant

    Three household names on the ASX have taken a hit following their latest results.

    Read more »

    A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
    Broker Notes

    Why Macquarie says the HUGE sell-off in CSL shares is way overdone

    | Bernd Struben

    Macquarie forecasts a big rebound is coming for CSL shares. But why?

    Read more »

    A man looking at his laptop and thinking.
    Share Market News

    5 things to watch on the ASX 200 on Wednesday

    | James Mickleboro

    Here's what to expect on the local market today.

    Read more »

    A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
    Share Market News

    Are CSL shares a buy after the brutal selloff?

    | James Mickleboro

    Bell Potter has given its verdict on the fallen biotech star.

    Read more »

    Bored man sitting at his desk with his laptop.
    Share Fallers

    Why CSL, HMC Capital, Reliance, and Suncorp shares are sinking today

    | James Mickleboro

    These shares are having a difficult time on Tuesday. But why?

    Read more »

    a couple clink champagne glasses on board a private aircraft with gourmet food plates set in front of them. They are wearing designer clothes and looking wealthy.
    Share Market News

    Why are wealthy investors offloading CBA shares and buying up CSL?

    | Bronwyn Allen

    It's out with the big ASX 200 bank and in with the healthcare blue-chip.

    Read more »

    A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
    Earnings Results

    CSL FY25 earnings: Revenue grows, Seqirus demerger ahead

    | Laura Stewart

    CSL delivered solid FY25 growth, announced a Seqirus demerger, and plans a fresh share buyback to support investors.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note